[1] Lim S,Koo BK,Cho SW,et al.Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes:the Korean atherosclerosis study ( KAS):a 42-month prospective study[J].Atherosclerosis,2008, 196( 1):398-404.
[2] Chen BH,Song Y,Ding EL, et al.Circulating levels of resistin and risk of type 2 diabetes in men and women:results from two prospective cohorts[J].Diabetes Care,2009,32( 2):329-334.
[3] American Diabetes Association.Standards of medical care in diabetes-2009[J].Diabetes Care,2009,32( Suppl 1):S13-S61.
[4] Steppan CM,Bailey ST,Bhat S, et al.The hormone resistin links obesity to diabetes[J].Nature,2001,409( 6818):307-312.
[5] 梁梅花,李强,张斤超,等.抵抗素与肥胖及2 型糖尿病的关系[J].中国糖尿病杂志,2007,15( 7):418-420.
[6] 李文侠,董庆玉,梁翠格,等.2 型糖尿病患者血清脂肪细胞因子与胰岛素抵抗的相关性研究[J].滨州医学院学报,2012,35( 1):23-26.
[7] Frankel DS,Vasan RS,D' Agostino RB Sr,et al.Resistin,adiponectin,and risk of heart failure the Framingham offspringstudy[J].J Am Coll Cardial, 2009,53( 9):754-762.
[8] Norata GD,Ongari M,Garlaschelli K, et al.Plasma resistin levels correlate with determinants of the metabolic syndrome[J].Eur J Endocrinol, 2007, 156( 2):279-284.
[9] Kadoglou NP,Perrea D, Iliadis F,et al.Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes[J].Diabetes Care,2007, 30( 3):719-721.